A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

被引：0
|
作者：
Midori Nakagaki
Michael Barras
Cameron Curley
Jason P. Butler
Glen A. Kennedy
机构：
[1] Royal Brisbane and Women’s Hospital,Pharmacy Department, Level 1 Ned Hanlon Building
[2] The University of Queensland,Bone Marrow Transplant Unit, Level 5 Joyce Tweddell Building
[3] Royal Brisbane and Women’s Hospital,undefined
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Stem cell transplantation; Antiemetics; Ondansetron; Palonosetron; Olanzapine; Nausea and vomiting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [31] A randomized pilot study comparing aprepitant to olanzapine for treatment of chemotherapy-induced nausea and vomiting
    Shumway, N. M.
    Terrazzino, S. E.
    Jones, C. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy
    Feinberg, Bruce
    Gilmore, James
    Haislip, Sally
    Jackson, James
    Jain, Gagan
    Balu, Sanjeev
    Buchner, Deborah
    SUPPORTIVE CARE IN CANCER, 2012, 20 (03) : 615 - 623
  • [33] A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
    Aapro, M. S.
    Grunberg, S. M.
    Manikhas, G. M.
    Olivares, G.
    Suarez, T.
    Tjulandin, S. A.
    Bertoli, L. F.
    Yunus, F.
    Morrica, B.
    Lordick, F.
    Macciocchi, A.
    ANNALS OF ONCOLOGY, 2006, 17 (09) : 1441 - 1449
  • [34] Daily Palonosetron Is Superior to Ondansetron in the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients With Acute Myelogenous Leukemia
    Mattiuzzi, Gloria N.
    Cortes, Jorge E.
    Blamble, Deborah A.
    Bekele, Nebiyou
    Xiao, Lianchun
    Cabanillas, Maria
    Borthakur, Gautam
    Brien, Susan O.
    Kantarjian, Hagop
    CANCER, 2010, 116 (24) : 5659 - 5666
  • [35] Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy
    Bruce Feinberg
    James Gilmore
    Sally Haislip
    James Jackson
    Gagan Jain
    Sanjeev Balu
    Deborah Buchner
    Supportive Care in Cancer, 2012, 20 : 615 - 623
  • [36] Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
    Uchiike, Akihiro
    Kono, Haruka
    Miura, Katsuhiro
    Hayama, Tatsuya
    Tsutsumi, Daisuke
    Tsuboi, Shinya
    Ohtsuka, Susumu
    Hidaka, Shinji
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2023, 9 (01)
  • [37] Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
    Akihiro Uchiike
    Haruka Kono
    Katsuhiro Miura
    Tatsuya Hayama
    Daisuke Tsutsumi
    Shinya Tsuboi
    Susumu Ohtsuka
    Shinji Hidaka
    Journal of Pharmaceutical Health Care and Sciences, 9
  • [38] Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly emetogenic chemotherapy-induced nausea and vomiting
    Kwon, J. H.
    Kang, J-H.
    Lee, Y-G.
    Park, K. U.
    An, H. J.
    Sohn, J.
    Seol, Y. M.
    Lee, H.
    Yun, H-J.
    Ahn, J. S.
    Kim, H. J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation
    Yeh, Su-Peng
    Lo, Woei-Chung
    Hsieh, Ching-Yun
    Bai, Li-Yuan
    Lin, Ching-Chan
    Lin, Po-Han
    Lin, Chen-Yuan
    Liao, Yu-Min
    Chiu, Chang-Fang
    SUPPORTIVE CARE IN CANCER, 2014, 22 (05) : 1199 - 1206
  • [40] A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
    Rudolph M. Navari
    Lawrence H. Einhorn
    Patrick J. Loehrer
    Steven D. Passik
    Jake Vinson
    John McClean
    Naveed Chowhan
    Nasser H. Hanna
    Cynthia S. Johnson
    Supportive Care in Cancer, 2007, 15
12345